These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7114316)

  • 1. Confusional paranoid psychosis after withdrawal from sympathomimetic amines: two case reports.
    Deveaugh-Geiss J; Pandurangi A
    Am J Psychiatry; 1982 Sep; 139(9):1190-1. PubMed ID: 7114316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narcolepsy, paranoid psychosis, and analeptic abuse.
    Leong GB; Shaner AL; Silva JA
    Psychiatr J Univ Ott; 1989 Sep; 14(3):481-3. PubMed ID: 2678193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of d-amphetamine withdrawal in rats and man.
    Johnson SW; Freedman R; Sorensen SM
    Am J Psychiatry; 1983 Jul; 140(7):953-4. PubMed ID: 6859334
    [No Abstract]   [Full Text] [Related]  

  • 4. Diethylpropion and paranoid psychosis.
    Petursson H
    Aust N Z J Psychiatry; 1979 Mar; 13(1):67-8. PubMed ID: 288469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diethylpropion and psychosis.
    Carney MW
    Clin Neuropharmacol; 1988 Apr; 11(2):183-8. PubMed ID: 3378228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postpartum psychosis with abnormal movements: dopamine supersensitivity unmasked by withdrawal of endogenous estrogens?
    Vinogradov S; Csernansky JG
    J Clin Psychiatry; 1990 Sep; 51(9):365-6. PubMed ID: 2211549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric disorder and diethylpropion hydrochloride.
    Carney MW; Harris M
    Practitioner; 1979 Oct; 223(1336):549-52. PubMed ID: 523407
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neuroleptic malignant syndrome with clozapine monotherapy and benign hyperthermia after resolving neuroleptic malignant syndrome with clozapine. Two case reports].
    Vetter P; Proppe D; Hoppe-Seyler S
    Nervenarzt; 1991 Jan; 62(1):55-7. PubMed ID: 2027422
    [No Abstract]   [Full Text] [Related]  

  • 9. A schizophreniform behavioral psychosis mediated by dopamine.
    Garver DL; Schlemmer RF; Maas JW; Davis JM
    Am J Psychiatry; 1975 Jan; 132(1):33-8. PubMed ID: 45537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone withdrawal psychosis.
    Levinson I; Galynker II; Rosenthal RN
    J Clin Psychiatry; 1995 Feb; 56(2):73-6. PubMed ID: 7852256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis.
    Sato M; Chen CC; Akiyama K; Otsuki S
    Biol Psychiatry; 1983 Apr; 18(4):429-40. PubMed ID: 6860719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained paranoid psychosis in a patient with mast cell leukemia and decreased serotonin level.
    Dasanu CA; Davis LK; Bauer F
    J Postgrad Med; 2013; 59(2):161-2. PubMed ID: 23793328
    [No Abstract]   [Full Text] [Related]  

  • 13. Flupenthixol versus haloperidol in acute psychosis.
    Parent M; Toussaint C
    Pharmatherapeutica; 1983; 3(5):354-64. PubMed ID: 6844372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of neuroleptic malignant syndrome in a narcoleptic patient.
    Chayasirisobhon S; Cullis P; Veeramasuneni RR
    Hosp Community Psychiatry; 1983 Jun; 34(6):548-50. PubMed ID: 6134661
    [No Abstract]   [Full Text] [Related]  

  • 15. Supersensitivity psychosis in a case with clozapine tolerance.
    Ozcan S; Soydan A; Tamam L
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():70-3. PubMed ID: 23090814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute paranoid psychosis as a result of dexamethasone withdrawal].
    Vitas B; Jakovljević M; Vitas M; Car N
    Lijec Vjesn; 1988; 110(3-4):94-6. PubMed ID: 3398692
    [No Abstract]   [Full Text] [Related]  

  • 17. [Paranoid psychosis in viral encephalitis: a case report].
    Helon B; Mikuła R
    Psychiatr Pol; 2003; 37(5):857-62. PubMed ID: 14631606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of haloperidol in residual schizophrenia and in the paranoid states].
    Jeri FR
    Rev Neuropsiquiatr; 1970 Jun; 33(2):114-22. PubMed ID: 5509272
    [No Abstract]   [Full Text] [Related]  

  • 19. Regional changes of cerebral blood flow during haloperidol therapy in patients with paranoid symptoms.
    Nilsson A; Risberg J; Johanson M; Gustafson L
    Acta Neurol Scand Suppl; 1977; 64():478-9. PubMed ID: 268882
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
    Greger J; Glitschka A; Müller K
    Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.